Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts

J Mol Cell Cardiol. 2000 Feb;32(2):233-46. doi: 10.1006/jmcc.1999.1068.

Abstract

Iron overload is associated with long-term cardiac iron accumulation and tissue changes such as fibrosis. To determine short-term iron-dependent changes in expression of genes associated with iron homeostasis and fibrosis we measured mRNA on Northern blots prepared from cultured rat neonatal cardiomyocytes and non-myocytes (fibroblasts) as a function of iron loading and chelation. Transferrin receptor mRNA was reduced in myocytes exposed to various concentrations of iron for 3 days and this decline was associated with a 63% decline in iron-response element (IRE) binding of iron regulatory protein-1, indicating that myocytes utilize IRE-dependent mechanisms to modulate gene expression. In myocytes iron caused a dose-dependent decline in mRNAs coding for transforming growth factor- beta(1)(TGF- beta(1)), biglycan, and collagen type I while plasminogen activator inhibitor-1 mRNA was unaffected by iron loading and decorin mRNA doubled. Total TGF- beta bioactivity was also decreased by iron loading. Thus, the effects of iron loading on genes related to cardiac fibrosis are gene-specific. Addition of deferoxamine for 1 day did not have any significant effect on any of these genes. Parallel changes in gene expression were exhibited by non-myocytes (fibroblasts), where chelation also decreased TGF- beta(1)mRNA and activity, and mRNA for collagen type I and biglycan, and collagen synthesis. In addition to these changes in transcripts associated with matrix formation the mRNA of the metabolic enzyme glyceraldehyde-3-phosphate dehydrogenase was unaffected by iron loading but doubled in both cell types upon treatment with deferoxamine. These findings suggest that in both cardiac myocytes and non-myocyte fibroblasts gene expression is coupled to intracellular iron pools by gene-specific and IRE-dependent and idependent mechanisms. This linkage may influence matrix deposition, a significant component of cardiac injury.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Cells, Cultured / drug effects
  • Chelation Therapy
  • Collagen / biosynthesis
  • Collagen / genetics
  • Culture Media, Conditioned / pharmacology
  • Deferoxamine / pharmacology
  • Disease Progression
  • Extracellular Matrix Proteins / biosynthesis
  • Extracellular Matrix Proteins / genetics
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Fibrosis
  • Gene Expression Regulation / drug effects*
  • Heart / drug effects*
  • Iron / metabolism
  • Iron / pharmacology*
  • Iron Chelating Agents / pharmacology
  • Iron Overload / genetics*
  • Iron Overload / metabolism
  • Iron Overload / pathology
  • Iron-Regulatory Proteins
  • Iron-Sulfur Proteins / biosynthesis
  • Iron-Sulfur Proteins / genetics
  • Lung
  • Mink
  • Muscle Proteins / biosynthesis*
  • Muscle Proteins / genetics
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Plasminogen Activator Inhibitor 1 / biosynthesis
  • Plasminogen Activator Inhibitor 1 / genetics
  • RNA, Messenger / biosynthesis
  • RNA-Binding Proteins / biosynthesis
  • RNA-Binding Proteins / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Regulatory Sequences, Nucleic Acid
  • Transforming Growth Factor beta / biosynthesis*
  • Transforming Growth Factor beta / genetics
  • Treatment Failure

Substances

  • Culture Media, Conditioned
  • Extracellular Matrix Proteins
  • Iron Chelating Agents
  • Iron-Regulatory Proteins
  • Iron-Sulfur Proteins
  • Muscle Proteins
  • Plasminogen Activator Inhibitor 1
  • RNA, Messenger
  • RNA-Binding Proteins
  • Transforming Growth Factor beta
  • Collagen
  • Iron
  • Deferoxamine